Sabra Healthcare REIT (SBRA) Posts Quarterly Earnings, Meets Expectations
Sabra Healthcare REIT (NASDAQ:SBRA) announced its earnings results on Wednesday. The company reported $0.46 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.46, Analyst RN reports. The company had revenue of $32.90 million for the quarter, compared to the consensus estimate of $33.01 million.
A number of analysts have recently weighed in on SBRA shares. Analysts at Jefferies Group upgraded shares of Sabra Healthcare REIT from a “hold” rating to a “buy” rating in a research note to investors on Wednesday, September 18th. They now have a $26.00 price target on the stock, down previously from $27.00. On a related note, analysts at RBC Capital raised their price target on shares of Sabra Healthcare REIT from $31.00 to $33.00 in a research note to investors on Monday, August 5th. They now have an “outperform” rating on the stock. Finally, analysts at Raymond James cut their price target on shares of Sabra Healthcare REIT from $28.00 to $27.00 in a research note to investors on Monday, August 5th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. Sabra Healthcare REIT has a consensus rating of “Buy” and a consensus price target of $29.00.
Sabra Healthcare REIT (NASDAQ:SBRA) traded up 2.03% on Wednesday, hitting $26.19. The stock had a trading volume of 656,421 shares. Sabra Healthcare REIT has a one year low of $19.54 and a one year high of $32.40. The stock has a 50-day moving average of $23.8 and a 200-day moving average of $27.15. The company has a market cap of $977.8 million and a P/E ratio of 64.17.
Sabra Health Care REIT, Inc (NASDAQ:SBRA) as a wholly owned subsidiary of Sun Healthcare Group, Inc, a provider of nursing, rehabilitative and related specialty healthcare services to the senior population in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.